Delivery Order 36F79723D0188-70CMSD23FR0000217
Award Date
9/15/23
Potential Completion Date
10/15/23
Potential Value
$20K
Federal Agency
Immigration and Customs Enforcement
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Emergent Devices, Inc. is for the delivery of naloxone hydrochloride nasal spray 4mg, a medication used to rapidly reverse opioid overdoses and treat substance abuse. The $107,458.56 Firm Fixed Price contract was awarded by the U.S. Immigration and Customs Enforcement (ICE) agency and does not have a set-aside designation. Emergent Devices is a for-profit manufacturer that holds a Federal Supply Schedule 65 IB contract with the Department of Veterans Affairs to...
The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
The Department of Homeland Security's Customs and Border Protection awarded Emergent Devices, Inc., a for-profit manufacturer, a $152,712 firm-fixed-price delivery order contract for NARCAN, a naloxone nasal spray used to rapidly reverse opioid overdoses. This order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceutical and hematology products, which runs through August 2028. Emergent Devices has previously provided NARCAN to other federal agencies,...
This federal contract award is for the delivery of NARCAN NASAL SPRAY to the Immigration and Customs Enforcement agency. The contract was awarded to Emergent Devices, Inc., a for-profit organization and manufacturer of pharmaceuticals and medical devices. The contract has a firm fixed price of $205,312.80 and was awarded on June 4, 2020, with a completion date of July 4, 2020. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the...
This is a federal contract award to Emergent Devices, Inc., a for-profit organization and manufacturer of goods, to provide NARCAN (naloxone nasal spray) to the Department of Homeland Security Customs and Border Protection. The contract is a Delivery Order valued at $288,456.00 and is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, which Emergent Devices holds through August 2028. The contract is not set aside. NARCAN is an overdose reversal medication that...
This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...
This is a delivery order contract awarded by U.S. Immigration and Customs Enforcement (ICE) to Emergent Devices, Inc., a manufacturer of pharmaceuticals and medical devices. The $334,414.08 contract is for the provision of NARCAN (naloxone) nasal spray, which rapidly reverses opioid overdoses. The order is placed against Emergent Devices' Federal Supply Schedule contract for pharmaceutical products. The contract does not have a small business set-aside. In addition to providing NARCAN to ICE,...
The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
The Department of Homeland Security Customs and Border Protection awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of nose spray. The contract, which has a potential value of $152,712.00, was awarded on June 12, 2020 and is set to be completed by June 30, 2020. The contract was issued under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). No set-aside designation was used for this award....